1 / 7

Morpholinos

Morpholinos. Mary Mullins, UPenn. 25-mer antisense oligonucleotide with modified bases containing morpholine ring, making them very stable. How do they work? Translation blocking: Designed to 5’ UTR of mRNA or in coding region close to ATG.

benard
Download Presentation

Morpholinos

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Morpholinos Mary Mullins, UPenn • 25-mer antisense oligonucleotide with modified bases • containing morpholine ring, making them very stable. • How do they work? • Translation blocking: Designed to 5’ UTR of mRNA • or in coding region close to ATG. • Monitor loss of protein with Ab or epitope tag. • Splice blocking: Designed to splice site junction. ***Monitor loss of splicing by RT-PCR, then sequence to determine if non-functional mRNA. (Beware: can block translation too!) • Great loss of function technique, if no mutant available.

  2. The Problems: controls are needed • Control for specificity of knock down • Rescue with mRNA NOT containing MO site. • Do double injection: 1st MO, 2nd mRNA. • Second MO, non-overlapping with first, produces same phenotype. • 5 bp mismatch MO--expect no effect. • Control MO suggested by Gene Tools NOT a control. • Nonspecific effect: delay in development. Age-matched • controls not appropriate. Need to developmentally • stage controls to morphants (stage-matched). • Nonspecific effect: widespread cell death. >4 ng/embryo, • but depends on the particular MO. See also Eisen and Smith, Development, 2008.

  3. Combined specific and non-specific MO effects Cell death assay uninjected WT + 8ng tsg MO + 8ng MO + 96 pg tsg mRNA Reduced head size is non-specific tsg MO defect. Note extensive cell death, BUT mild head reduction. Vein edema is specifictsg MO defect. Use p53 mutant or p53 MO to block cell death. Little and Mullins, 2004

  4. Crosses—separate male from female in divided mating box, put together at various times in morning so can inject one-cell stage embryos throughout the morning. Titrating MO or mRNA—determining the right concentration Combine two different MOs targeted to same mRNA to reduce off-target effects.

  5. Today MOs smad5 smad5 mismatch bmp7 bmp7 mismatch mRNA for rescue of MO mouse smad5 Xenopus bmp7 MOs can be flourescently tagged, so can assess where injected/located. More expensive than non-tagged.

  6. James will demonstrate calibration of needle this morning.

  7. After calibrating needle, Then start MO injections Also……. check injected embryos from yesterday: Overexpression chordin, bmp4 Rescue of somitabun (smad5 mutant)

More Related